Stratos Genomics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $250M

Stratos Genomics General Information

Description

Developer of a genome sequencing technology intended to establish the next gold standard of DNA sequencing. The company's technology uses a simple biochemical reaction to encode the sequence of a DNA molecule into a highly measurable surrogate that encodes the sequence information in high signal-to-noise reporters that enable high-fidelity, single-molecule sequencing in a low-cost nanopore instrument, enabling scientists and clinicians to avail versatile and low-cost DNA sequencing methods.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • World Trade Center East
  • 2211 Elliott Avenue, Suite 210
  • Seattle, WA 98121
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • World Trade Center East
  • 2211 Elliott Avenue, Suite 210
  • Seattle, WA 98121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stratos Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 20-May-2020 $250M Completed Generating Revenue
8. Later Stage VC (Series B3) 08-Jan-2018 Completed Generating Revenue
7. Later Stage VC (Series B) 16-Jun-2015 Completed Generating Revenue
6. Later Stage VC 04-Sep-2013 Completed Generating Revenue
5. Early Stage VC 15-Oct-2012 Completed Generating Revenue
4. Grant 25-Aug-2011 Completed Startup
3. Early Stage VC (Series A3) 08-Jun-2011 Completed Startup
2. Early Stage VC (Series A2) 03-Aug-2010 $3.97M $4.41M Completed Startup
1. Early Stage VC (Series A1) $440K $440K Completed Startup
To view Stratos Genomics’s complete valuation and funding history, request access »

Stratos Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B3
Series B2
Series B1
Series A5
Series A4
Series A3
Series A2 1,435,766 $0.001000 8% $2.66 $2.66 1x $2.65 8.98%
Series A1 270,672 $0.001000 8% $1.66 $1.66 1x $1.66 1.69%
To view Stratos Genomics’s complete cap table history, request access »

Stratos Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genome sequencing technology intended to establish the next gold standard of DNA sequencing. The company'
Other Pharmaceuticals and Biotechnology
Seattle, WA
60 As of 2020

Seraing, Belgium
 

Aliso Viejo, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stratos Genomics Competitors (25)

One of Stratos Genomics’s 25 competitors is Diagenode, a Formerly VC-backed company based in Seraing, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Diagenode Formerly VC-backed Seraing, Belgium
Ambry Genetics Formerly PE-Backed Aliso Viejo, CA
Egenesis Venture Capital-Backed Cambridge, MA
GnuBIO Formerly VC-backed Cambridge, MA
Biocept Formerly VC-backed San Diego, CA
You’re viewing 5 of 25 competitors. Get the full list »

Stratos Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stratos Genomics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fisk Ventures Family Office Minority
Roche Venture Fund Corporate Venture Capital Minority
Stratos Group Accelerator/Incubator Minority
To view Stratos Genomics’s complete investors history, request access »

Stratos Genomics FAQs

  • When was Stratos Genomics founded?

    Stratos Genomics was founded in 2007.

  • Where is Stratos Genomics headquartered?

    Stratos Genomics is headquartered in Seattle, WA.

  • What is the size of Stratos Genomics?

    Stratos Genomics has 60 total employees.

  • What industry is Stratos Genomics in?

    Stratos Genomics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Stratos Genomics a private or public company?

    Stratos Genomics is a Private company.

  • What is the current valuation of Stratos Genomics?

    The current valuation of Stratos Genomics is .

  • What is Stratos Genomics’s current revenue?

    The current revenue for Stratos Genomics is .

  • How much funding has Stratos Genomics raised over time?

    Stratos Genomics has raised $61.1M.

  • Who are Stratos Genomics’s investors?

    Fisk Ventures, Roche Venture Fund, and Stratos Group have invested in Stratos Genomics.

  • Who are Stratos Genomics’s competitors?

    Diagenode, Ambry Genetics, Egenesis, GnuBIO, and Biocept are some of the 25 competitors of Stratos Genomics.

  • When was Stratos Genomics acquired?

    Stratos Genomics was acquired on 20-May-2020.

  • Who acquired Stratos Genomics?

    Stratos Genomics was acquired by Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process